Back to GLENMEDE TRUST CO NA GLENMEDE TRUST CO NA

ARWRARWR
24 quarters

Position history for GLENMEDE TRUST CO NAGLENMEDE TRUST CO NA's holdings in ARROWHEAD PHARMACEUTICALS IN

GLENMEDE TRUST CO NA holds 2,942 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $239,802 as of 2026-Q2. This is a new position. ARWR represents 0.0% of GLENMEDE TRUST CO NA's portfolio.

Current Value

$239,802

Current Shares

2,942

Total Value Change

+$48,802

Total Shares Change

-7,058

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
2,942
-
$239,8020.0%$81.51
32
2024-Q1
Exited
0
-100.0%
$00.0%$28.60
0
2023-Q4
Decreased
16,190
-4.2%
$495,4140.0%$30.60
0
2023-Q3
Increased
16,905
+68.6%
$454,2370.0%$26.87
35
2023-Q2
Unchanged
10,029
0.0%
$254,7360.0%$35.93
0
2023-Q1
Decreased
10,029
-36.0%
$254,7360.0%$24.43
0
2022-Q4
Increased
15,663
+1.3%
$635,2910.0%$40.56
25
2022-Q3
Increased
15,462
+54.5%
$510,0000.0%$33.28
34
2022-Q2
Unchanged
10,007
0.0%
$352,0000.0%$34.56
0
2022-Q1
Decreased
10,007
-0.1%
$459,0000.0%$45.59
0
2021-Q4
Increased
10,018
+0.1%
$664,0000.0%$67.35
24
2021-Q3
Decreased
10,007
-0.3%
$624,0000.0%$60.63
0
2021-Q2
Increased
10,038
+0.3%
$831,0000.0%$81.50
25
2021-Q1
Decreased
10,007
-0.1%
$663,0000.0%$63.69
0
2020-Q4
Increased
10,018
+0.2%
$768,0000.0%$77.43
25
2020-Q3
Decreased
10,000
-0.3%
$430,0000.0%$43.42
0
2020-Q2
Decreased
10,028
-6.3%
$432,0000.0%$42.60
0
2020-Q1
Unchanged
10,697
0.0%
$678,0000.0%$28.97
0
2019-Q4
Increased
10,697
+0.5%
$678,0000.0%$64.20
25
2019-Q3
Increased
10,643
+3.7%
$299,0000.0%$26.96
24
2019-Q2
Increased
10,267
+2.7%
$272,0000.0%$26.50
24
2019-Q1
Unchanged
10,000
0.0%
$183,0000.0%$18.35
0
2018-Q4
Unchanged
10,000
0.0%
$124,0000.0%$11.94
0
2018-Q3
New
10,000
-
$191,0000.0%$19.17
31

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used